COVID-19 Trials in Porto Alegre, Brazil
Conditions / COVID-19 / Porto Alegre, Brazil
Research into COVID-19 spans multiple therapeutic approaches and trial phases.
40 total trials for this combination
Showing top 10 of 40 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05605093 | Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir) | TERMINATED | PHASE3 |
| NCT05543616 | A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children | RECRUITING | PHASE2/PHASE3 |
| NCT04421027 | A Study of Baricitinib (LY3009104) in Participants With COVID-19 | COMPLETED | PHASE3 |
| NCT04591210 | The COVID-RASi Trial (COVID-19) | COMPLETED | PHASE3 |
| NCT04426695 | Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 | COMPLETED | PHASE1/PHASE2 |
| NCT05011513 | Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). | TERMINATED | PHASE2/PHASE3 |
| NCT04615949 | Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors | TERMINATED | — |
| NCT05629962 | SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19 | COMPLETED | PHASE3 |
| NCT04723394 | Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults | COMPLETED | PHASE3 |
| NCT04615949 | Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors | TERMINATED | — |